RJF Stock Analysis: Raymond James Financial | NYSE
Asset Management | NYSE, USA | Market Cap: 30.984m USD | 12M Return: 0.9% | US7547301090 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 188M
EPS Trend: 93.2%
Qual. Beats: 2
Rev. Trend: 98.2%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Raymond James Financial, Inc. (RJF) is a diversified financial services holding company headquartered in Saint Petersburg, Florida, founded in 1962 and listed on the NYSE since 1987. The firm operates through five reportable segments-Private Client Group, Capital Markets, Asset Management, Bank, and Other-serving individuals, corporations, and municipalities across the United States, Canada, and Europe. RJF is classified within the Investment Banking & Brokerage sub-industry and functions as a bank holding company, combining a traditional broker-dealer with a federally chartered bank subsidiary.
The Private Client Group is the firms largest segment, providing financial planning, investment advisory, portfolio management, securities transaction execution, insurance and annuity products, and mutual fund distribution. It also delivers back-office support such as recordkeeping, custodial, and trade execution services to third-party mutual fund and annuity companies. Financial advisory firms in this segment typically operate under a hybrid model, with advisors often affiliated as independent contractors tied to the firm through recruiting, technology, and compliance support.
The Capital Markets segment offers investment banking services including equity and debt underwriting and merger and acquisition advisory, alongside institutional sales, equity research, fixed income and equity brokerage, and syndication of low-income housing and similar investment funds. The Asset Management segment provides portfolio management and related administrative services to both retail and institutional clients, generally through affiliated investment managers.
The Bank segment extends securities-based, commercial and industrial, commercial real estate, residential mortgage, and tax-exempt lending, while also gathering FDIC-insured deposits from retail and corporate clients and offering liquidity management products. The Other segment holds private equity investments, including interests in third-party funds.
- Net interest margin expands with sustained higher interest rates
- Private Client Group revenue grows on advisor recruiting and AUM gains
- Capital Markets fees rebound as M&A and underwriting activity recovers
| Net Income: 2.37b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.0 > 0.02 and ΔFCF/TA -2.55 > 1.0 |
| NWC/Revenue: error (cannot be calculated; needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA 0.0 > 3% & CFO 0.0 > Net Income 2.37b |
| Net Debt (5.64b) to EBITDA (3.08b): 1.84 < 3 |
| Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities) |
| Outstanding Shares: last quarter (195.6m) vs 12m ago -5.32% < -2% |
| Gross Margin: 86.06% > 18% (prev 87.99%; Δ -1.93% > 0.5%) |
| Asset Turnover: 38.62% > 50% (prev 17.78%; Δ 20.84% > 0%) |
| Interest Coverage Ratio: 1.76 > 6 (EBIT TTM 3.08b / Interest Expense TTM 1.75b) |
As of November 01, 2026, the stock is trading at USD 157.22 with a total of 1,582,247 shares traded. Over the past week, the price has changed by -0.30%, over one month by -1.31%, over three months by -9.84% and over the past year by +0.89%.
Current recommended Stop Loss: 152.50 (which is 3% or 1.4 ATR below the current price).
Raymond James Financial has received a consensus analysts rating of 3.56. Therefore, it is recommended to hold RJF.
- StrongBuy: 3
- Buy: 3
- Hold: 10
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 182.1 | 15.9% |
P/E Trailing = 13.5424
P/E Forward = 11.1982
P/S = 2.0331
P/B = 2.3116
P/EG = 0.7727
Revenue TTM = 17.1b USD
EBIT TTM = 3.08b USD
EBITDA TTM = 3.08b USD
Long Term Debt = 4.22b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.80b USD (from shortTermDebt, two quarters ago)
Debt = 5.64b USD (from shortLongTermDebtTotal, two quarters ago) + Leases 345.0m
Net Debt = 5.64b USD (using Total Debt 5.64b, CCE unavailable)
Enterprise Value = 36.6b USD (31.0b + Debt 5.64b - (null CCE))
Interest Coverage Ratio = 1.76 (Ebit TTM 3.08b / Interest Expense TTM 1.75b)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 36.6b)
FCF Margin = 0.0% (FCF TTM 0.0 / Revenue TTM 17.1b)
Net Margin = 13.87% (Net Income TTM 2.37b / Revenue TTM 17.1b)
Gross Margin = 86.06% ((Revenue TTM 17.1b - Cost of Revenue TTM 2.38b) / Revenue TTM)
Gross Margin QoQ = none% (prev 66.21%)
Tobins Q-Ratio = 236.3 (set to none) (Enterprise Value 36.6b / Total Assets 155.0m)
Interest Expense / Debt = 30.97% (Interest Expense 1.75b / Debt 5.64b)
Taxrate = 22.99% (707.0m / 3.08b)
NOPAT = 2.37b (EBIT 3.08b * (1 - 22.99%))
Current Ratio = unknown (Total Current Assets 24.8b / Total Current Liabilities none)
Debt / Equity = 0.44 (Debt 5.64b / totalStockholderEquity, two quarters ago 12.7b)
Debt / EBITDA = 1.84 (Net Debt 5.64b / EBITDA 3.08b)
Debt / FCF = unknown (Net Debt 5.64b / FCF TTM 0.0)
Total Stockholder Equity = 12.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.36% (Net Income 2.37b / Total Assets 155.0m)
RoE = 18.82% (Net Income TTM 2.37b / Total Stockholder Equity 12.6b)
RoCE = 18.30% (EBIT 3.08b / Capital Employed (Equity 12.6b + L.T.Debt 4.22b))
RoIC = unknown (NOPAT 2.37b, Invested Capital 0.0, EBIT 3.08b)
WACC = 10.65% (E(31.0b)/V(36.6b) * Re(8.25%) + D(5.64b)/V(36.6b) * Rd(30.97%) * (1-Tc(0.23)))
Discount Rate = 8.25% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.12 | Cagr: -3.58%
[DCF] Fair Price = unknown (Cash Flow 0.0)
EPS Correlation: 93.23 | EPS CAGR: 12.41% | SUE: 1.38 | # QB: 2
Revenue Correlation: 98.23 | Revenue CAGR: 8.68% | SUE: 2.48 | # QB: 1
EPS current Quarter (2026-12-31): EPS=3.36 | Chg30d=-0.05% | Revisions=+18% | Analysts=11
EPS next Quarter (2027-03-31): EPS=3.46 | Chg30d=-0.41% | Revisions=+18% | Analysts=11
EPS current Year (2027-09-30): EPS=14.30 | Chg30d=+0.75% | Revisions=+30% | GrowthEPS=+15.3% | GrowthRev=+12.3%
EPS next Year (2028-09-30): EPS=16.21 | Chg30d=+1.34% | Revisions=+0% | GrowthEPS=+13.3% | GrowthRev=+6.4%
[Analyst] Revisions Ratio: +25% (up=16, down=9)